Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development
HOLON, Israel, Jan. 8, 2020 -- (Healthcare Sales & Marketing Network) -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the appointment of Oliver Froescheis, Ph.D., ... Biopharmaceuticals, Oncology, Personnel Compugen, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | Israel Health | Marketing | Middle East Health | Pharmaceuticals